Provenance du réseau au premier degré de Robert Bender
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
Nometics, Inc.
 Nometics, Inc. Pharmaceuticals: MajorHealth Technology Nometics, Inc. operates as a specialty pharmaceutical company. It focuses on the treatment of cancer through the restoration of the nitric oxide signaling pathway. The company is headquartered in Toronto, Canada.
2
| Holding Company | Pharmaceuticals: Major | 2 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Robert Bender via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
Cortria Corp.
 Cortria Corp. Pharmaceuticals: MajorHealth Technology Cortria Corp. operates as a clinical-stage pharmaceutical company that focuses on developing medicines to fight cardiovascular disease. Its product is used for the treatment of dyslipidemia, an atherogenic disorder characterized by abnormal lipid levels in the bloodstream. The company was founded in August 2005 and is headquartered in Needham, MA. | Pharmaceuticals: Major | General Counsel | |
| University of Georgia | College/University | Undergraduate Degree | |
Otsuka America Pharmaceutical, Inc.
 Otsuka America Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Otsuka America Pharmaceutical, Inc. manufactures and supplies pharmaceutical products. It develops drugs for neuroscience, cardiovascular, and gastrointestinal treatments. The company was founded in 1989 and is headquartered in Rockville, MD. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Cardioxyl Pharmaceuticals LLC
 Cardioxyl Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Cardioxyl Pharmaceuticals, Inc. discovers and develops therapies and technologies for the treatment of cardiovascular diseases. It offers nitroxyl therapeutics, including CXL-1020, a nitroxyl donor compound for the intravenous treatment of acute decompensated heart failure and nitroxyl donor compounds for unmet medical needs in other cardiovascular indications. The company was founded by Vincent J. Kalish and Douglas Cowart in 2005 and is headquartered in Chapel Hill, NC. | Pharmaceuticals: Major | Founder | |
Leadiant Biosciences, Inc.
 Leadiant Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Leadiant Biosciences, Inc. operates as a research-based pharmaceutical company. It develops and commercializes medicines for rare diseases. The company was founded in 1989 by Claudio Cavazza and is headquartered in Gaithersburg, MD. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Medical University of South Carolina | College/University | Doctorate Degree |
Statistiques
Internationale
| Etats-Unis | 8 |
Sectorielle
| Health Technology | 5 |
| Consumer Services | 3 |
| Commercial Services | 2 |
Opérationnelle
| General Counsel | 3 |
| Corporate Officer/Principal | 3 |
| Undergraduate Degree | 1 |
| Chief Operating Officer | 1 |
| Founder | 1 |
Relations les plus connectées
| Insiders | |
|---|---|
| Douglas Cowart | 8 |
| Fred Saad | 1 |
- Bourse
- Insiders
- Robert Bender
- Connexions Sociétés
